Alum
Showing 26 - 50 of 199
HIV Trial in United States (MN rgp120/HIV-1 and A244 rgp120/HIV-1, QS-21, rgp120/HIV-1MN)
Completed
- HIV Infections
- MN rgp120/HIV-1 and A244 rgp120/HIV-1
- +2 more
-
Baltimore, Maryland
- +3 more
Oct 28, 2021
COVID-19 Trial in Taiyuan, Chengdu (Candidate Vaccine, SCB-2019, Placebo)
Active, not recruiting
- COVID-19
- Candidate Vaccine, SCB-2019
- Placebo
-
Taiyuan, Shanxi, China
- +1 more
Feb 22, 2022
COVID-19 Trial in Semarang, Makassar, Padang (SARS-CoV-2 protein subunit recombinant vaccine, )
Active, not recruiting
- COVID-19
- SARS-CoV-2 protein subunit recombinant vaccine
- placebo
-
Semarang, Central Java, Indonesia
- +2 more
Aug 8, 2022
Diabetes, Type 1, Prediabetic State Trial in Malmö (Alum-GAD, Vitamin D3)
Terminated
- Diabetes Mellitus, Type 1
- Prediabetic State
- Alum-GAD
- Vitamin D3
-
Malmö, SwedenClinical Research Center, Pediatric Endocrinology, Jan Waldenstr
Oct 27, 2020
COVID-19 Trial in Indonesia (COVID-19 Protein Subunit Recombinant Vaccine, Active Comparator)
Recruiting
- COVID-19
- COVID-19 Protein Subunit Recombinant Vaccine
- Active Comparator
-
Semarang, Central Java, Indonesia
- +3 more
Jun 26, 2022
Hiv Trial in United States (V3G CH848 Pr-NP1 60mcg, 3M-052-AF 5mcg, Alum 500 mcg)
Not yet recruiting
- Hiv
- V3G CH848 Pr-NP1 60mcg
- +5 more
-
Birmingham, Alabama
- +5 more
Jun 5, 2023
HIV Trial in South Africa, United States (sD-NP-GT8 DNA, IL-12 DNA, Trimer 4571)
Not yet recruiting
- HIV Infections
- sD-NP-GT8 DNA
- +4 more
-
Birmingham, Alabama
- +5 more
Mar 10, 2023
Chikungunya Virus Infection Trial in Lenexa, Kansas City, West Jordan (CHIKV VLP/unadjuvanted, CHIKV VLP/adjuvanted, Placebo)
Completed
- Chikungunya Virus Infection
- CHIKV VLP/unadjuvanted
- +2 more
-
Lenexa, Kansas
- +2 more
Oct 12, 2021
HIV Trial in Mozambique, South Africa, Zimbabwe (ALVAC-HIV (vCP2438), Bivalent Subtype C gp120/MF59, Bivalent Subtype C gp120
Completed
- HIV Infections
- ALVAC-HIV (vCP2438)
- +3 more
-
Maputo, Mozambique
- +5 more
Nov 18, 2021
Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)
Respiratory Syncytial Virus Trial run by the NIAID (VRC-RSVRGP084-00-VP, Aluminum Hydroxide Suspension)
Completed
- Respiratory Syncytial Virus
- VRC-RSVRGP084-00-VP
- Aluminum Hydroxide Suspension
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 21, 2020
HIV, HIV Seronegativity Trial in Baltimore (Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203), Aluminum hydroxide, MF59)
Completed
- HIV Infections
- HIV Seronegativity
- Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)
- +3 more
-
Baltimore, MarylandJHU AVEG
Oct 27, 2021
Staphylococcal Infections, Yeast Infections, Candidiasis Trial in Fargo (NDV-3 vaccine with alum IM, NDV-3 vaccine without alum
Completed
- Staphylococcal Infections
- +2 more
- NDV-3 vaccine with alum IM
- +3 more
-
Fargo, North DakotaCetero Research Clinical Site
Feb 20, 2020
Zika Virus Infection Trial in Silver Spring (IXIARO, Placebo, YF Vax 17D Strain)
Completed
- Zika Virus Infection
- IXIARO
- +3 more
-
Silver Spring, MarylandWalter Reed Army Institute of Research - Clinical Trials Center
Sep 3, 2020
COVID-19 Trial in Worldwide (CpG 1018/Alum-adjuvanted SCB-2019 vaccine, Placebo; 0.9% saline, SCB-2019 vaccine)
Recruiting
- COVID-19
- CpG 1018/Alum-adjuvanted SCB-2019 vaccine
- +3 more
-
Alken, Belgium
- +30 more
Feb 7, 2022
Venezuelan Equine Encephalitis, Western Equine Encephalitis, Eastern Equine Encephalitis Trial in Decatur (VRC-WEVVLP073-00-VP,
Completed
- Venezuelan Equine Encephalitis
- +3 more
- VRC-WEVVLP073-00-VP
- VRC-GENMIX083-AL-VP
-
Decatur, GeorgiaThe Hope Clinic of the Emory Vaccine Center
Mar 23, 2021
Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)
Completed
- Diabetes Mellitus, Type 1
- GAD-Alum
- Vitamin D
-
Linköping, SwedenLinköping University
Apr 15, 2020
Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)
Taste-aware Intelligent Analysis of Oral Nutritional Supplements
Not yet recruiting
- Cancer- and Cancer Treatment-Related Conditions
- Stroke
- Samples materials of basic taste stimuli and enteral nutrition preparations
-
Beijing, Beijing, ChinaDongcheng district,Peking union medical college hospital
Dec 5, 2022
Induced by Allergy Immunotherapy (AIT) With Different Adjuvants
Completed
- Allergic Rhinitis
- Allergovit
- +2 more
-
Zurich, SwitzerlandUniveristy Hospital Zurich
Mar 22, 2022
Shingles, Herpes Zoster, Vaccine-Preventable Diseases Trial in Australia (Z-1018, Shingrix)
Recruiting
- Shingles
- +2 more
- Z-1018
- Shingrix
-
Blacktown, New South Wales, Australia
- +3 more
Feb 8, 2022
HIV Trial in Boston (CH505 TF chTrimer, 3M-05-AF, Aluminum hydroxide suspension)
Active, not recruiting
- HIV Infections
- CH505 TF chTrimer
- +2 more
-
Boston, MassachusettsBrigham and Women's CRS
Jan 31, 2022
Pneumonia, Pneumococcal Trial in Kisumu (PATH-wSP, Synflorix, Pentavac)
Completed
- Pneumonia, Pneumococcal
- PATH-wSP
- +3 more
-
Kisumu, Nyanza, KenyaKenya Medical Research Institute/Walter Reed Project
Oct 1, 2019
COVID-19 Vaccine Trial in Argentina (Gamma Variant RBD-based ARVAC-CG vaccine, Omicron Variant RBD-based ARVAC-CG vaccine,
Recruiting
- COVID-19 Vaccine
- Gamma Variant RBD-based ARVAC-CG vaccine
- +3 more
-
Argentina, C.a.b.a., ArgentinaCentro de Educación Médica e Investigaciones Clínicas "Norberto
Feb 28, 2023